Revising the role of myeloid cells in HIV pathogenesis

Current HIV/AIDS Reports

Volumn 10, Issue 1, 2013, Pages 3-11

  Aggarwal, Anupriya ^a   McAllery, Samantha ^a   Turville, Stuart G ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

CD4 T cells; Dendritic cells; HIV; HIV pathogenesis and treatment; HIV restriction factors; Macrophages; Myeloid cells; SAMHD1; SIV VPX

Indexed keywords

ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; DENDRITIC CELL; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INOCULATION; LENTIVIRINAE; MACACA; MACROPHAGE; MONOCYTE; NONHUMAN; RHESUS MONKEY; SEMINAL PLASMA; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HIV-1; HUMANS; MACACA MULATTA; MONOMERIC GTP-BINDING PROTEINS; MYELOID CELLS; PSEUDOPODIA; VIRUS ASSEMBLY;

EID: 84873724506     PISSN: 15483568     EISSN: 15483576     Source Type: Journal    
DOI: 10.1007/s11904-012-0149-1     Document Type: Article

References (99)

1. Narayan O, Kennedy-Stoskopf S, Zink MC. Lentivirus-host interactions: lessons from visna and caprine arthritis-encephalitis viruses. Ann Neurol. 1988;23(Suppl):S95-S100.
2. Gendelman HE, Narayan O, Molineaux S, Clements JE, Ghotbi Z. Slow, persistent replication of lentiviruses: role of tissue macrophages and macrophage precursors in bone marrow. Proc Natl Acad Sci U S A. 1985;82:7086-90. (Pubitemid 16209697)
3. Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S, et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature. 2011;474:658-61.
4. •• Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Segeral E, et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature. 2011;474:654-7. Discovery of the VPX binding partner SAMHD1 and its role in viral restriction in DC and macrophages.
5. Koenig S, Gendelman HE, Orenstein JM, Dal Canto MC, Pezeshkpour GH, Yungbluth M, et al. Detection of AIDS. virus in macrophages in brain tissue from AIDS. patients with encephalopathy. Science. 1986;233:1089-93. (Pubitemid 16032241)
6. Merrill JE, Chen IS. HIV-1, macrophages, glial cells, and cytokines in AIDS. nervous system disease. FASEB J. 1991;5:2391-7. (Pubitemid 21905786)
7. Orenstein JM, Fox C, Wahl SM. Macrophages as a source of HIV during opportunistic infections. Science. 1997;276:1857-61.
8. Wahl SM, Greenwell-Wild T, Peng G, Hale-Donze H, Doherty TM, Mizel D, et al. Mycobacterium avium complex augments macrophage HIV-1 production and increases CCR5 expression. Proc Natl Acad Sci U S A. 1998;95:12574-9. (Pubitemid 28483806)
9. Frankel SS, Wenig BM, Burke AP, Mannan P, Thompson LD, Abbondanzo SL, et al. Replication of HIV-1 in dendritic cell-derived syncytia at the mucosal surface of the adenoid. Science. 1996;272:115-7. (Pubitemid 26110764)
10. Frankel SS, Tenner-Racz K, Racz P, Wenig BM, Hansen CH, Heffner D, et al. Active replication of HIV-1 at the lymphoepithelial surface of the tonsil. Am J Pathol. 1997;151:89-96. (Pubitemid 27283961)
11. Orenstein JM. HIV expression in surgical specimens. AIDS Res Hum Retrovir. 2008;24:947-55.
12. Quayle AJ, Xu C, Mayer KH, Anderson DJ. T lymphocytes and macrophages, but not motile spermatozoa, are a significant source of human immunodeficiency virus in semen. J Infect Dis. 1997;176:960-8. (Pubitemid 27411038)
13. Hu Q, Frank I, Williams V, Santos JJ, Watts P, Griffin GE, et al. Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue. J Exp Med. 2004;199:1065-75. (Pubitemid 38619903)
14. Miller CJ, Hu J. T cell-tropic simian immunodeficiency virus (SIV) and simian-human immunodeficiency viruses are readily transmitted by vaginal inoculation of rhesus macaques, and Langerhans' cells of the female genital tract are infected with SIV. J Infect Dis. 1999;179 Suppl 3:S413-7. (Pubitemid 29198388)
15. Spira AI, Marx PA, Patterson BK, Mahoney J, Koup RA, Wolinsky SM, et al. Cellular targets of infection and route of viral dissemination after an intravaginal inoculation of simian immunodeficiency virus into rhesus macaques. J Exp Med. 1996;183:215-25. (Pubitemid 26028761)
16. Ellery PJ, Tippett E, Chiu YL, Paukovics G, Cameron PU, Solomon A, et al. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol. 2007;178:6581-9. (Pubitemid 46717442)
17. Jaworowski A, Kamwendo DD, Ellery P, Sonza S, Mwapasa V, Tadesse E, et al. CD16+ monocyte subset preferentially harbors HIV-1 and is expanded in pregnant Malawian women with Plasmodium falciparum malaria and HIV-1 infection. J Infect Dis. 2007;196:38-42. (Pubitemid 46982735)
18. Pope M, Gezelter S, Gallo N, Hoffman L, Steinman RM. Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells. J Exp Med. 1995;182:2045-56.
19. Reece JC, Handley AJ, Anstee EJ, Morrison WA, Crowe SM, Cameron PU. HIV-1 selection by epidermal dendritic cells during transmission across human skin. J Exp Med. 1998;187:1623-31. (Pubitemid 28235103)
20. Kawamura T, Gulden FO, Sugaya M, McNamara DT, Borris DL, Lederman MM, et al. R5 HIV productively infects Langerhans cells, and infection levels are regulated by compound CCR5 polymorphisms. Proc Natl Acad Sci U S A. 2003;100:8401-6. (Pubitemid 36842557)
21. Kawamura T, Cohen SS, Borris DL, Aquilino EA, Glushakova S, Margolis LB, et al. Candidate microbicides block HIV-1 infection of human immature Langerhans cells within epithelial tissue explants. J Exp Med. 2000;192:1491-500.
22. Zhang Z, Schuler T, Zupancic M, Wietgrefe S, Staskus KA, Reimann KA, et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cells. Science. 1999;286:1353-7. (Pubitemid 29535894)
23. Zhang ZQ, Wietgrefe SW, Li Q, Shore MD, Duan L, Reilly C, et al. Roles of substrate availability and infection of resting and activated CD4+ T cells in transmission and acute simian immunodeficiency virus infection. Proc Natl Acad Sci U S A. 2004;101:5640-5. (Pubitemid 38481209)
24. Lackner AA, Veazey RS. Current concepts in AIDS. pathogenesis: insights from the SIV/macaque model. Annu Rev Med. 2007;58:461-76. (Pubitemid 46706527)
25. McDermott AB, Mitchen J, Piaskowski S, De Souza I, Yant LJ, Stephany J, et al. Repeated low-dose mucosal simian immunodeficiency virus SIVmac239 challenge results in the same viral and immunological kinetics as high-dose challenge: a model for the evaluation of vaccine efficacy in nonhuman primates. J Virol. 2004;78:3140-4. (Pubitemid 38314372)
26. Chakraborty H, Sen PK, Helms RW, Vernazza PL, Fiscus SA, Eron JJ, et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS. 2001;15:621-7. (Pubitemid 32281358)
27. Tachet A, Dulioust E, Salmon D, De Almeida M, Rivalland S, Finkielsztejn L, et al. Detection and quantification of HIV-1 in semen: identification of a subpopulation of men at high potential risk of viral sexual transmission. AIDS. 1999;13:823-31. (Pubitemid 29224585)
28. Daniel MD, Letvin NL, King NW, Kannagi M, Sehgal PK, Hunt RD, et al. Isolation of T-cell tropic HTLV-III-like retrovirus from macaques. Science. 1985;228:1201-4. (Pubitemid 15232892)
29. Reimann KA, Li JT, Veazey R, Halloran M, Park IW, Karlsson GB, et al. A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS.-like disease after in vivo passage in rhesus monkeys. J Virol. 1996;70:6922-8. (Pubitemid 26307405)
30. Harouse JM, Gettie A, Tan RC, Blanchard J, Cheng-Mayer C. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science. 1999;284:816-9. (Pubitemid 29291349)
31. Ambrose Z, Palmer S, Boltz VF, Kearney M, Larsen K, Polacino P, et al. Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy. J Virol. 2007;81:12145-55. (Pubitemid 350085830)
32. Stremlau M, Owens CM, Perron MJ, Kiessling M, Autissier P, Sodroski J. The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys. Nature. 2004;427:848-53. (Pubitemid 38297747)
33. Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, Watt IN, et al. DNA deamination mediates innate immunity to retroviral infection. Cell. 2003;113:803-9. (Pubitemid 36724943)
34. Hatziioannou T, Ambrose Z, Chung NP, Piatak Jr M, Yuan F, Trubey CM, et al. A macaque model of HIV-1 infection. Proc Natl Acad Sci U S A. 2009;106:4425-9.
35. •• Baldauf HM, Pan X, Erikson E, Schmidt S, Daddacha W, Burggraf M, et al. SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nat Med. 2012;18:1682-9. Seminal and important contribution to demonstrate the SAMHD1 phenotype is not myeloid-cell-specific, but rather covers all resting cell types, including resting CD4 T cells.
36. • Berger A, Sommer AF, Zwarg J, Hamdorf M, Welzel K, Esly N, et al. SAMHD1-deficient CD14+ cells from individuals with Aicardi-Goutieres syndrome are highly susceptible to HIV-1 infection. PLoS Pathog. 2011;7:e1002425. Ex vivo monocytes from patients deficient of SAMHD1 can be readily infected with HIV. Further evidence independently supporting in vitro protein knock down data and that ex vivo monocytes also restrict infection with this particular restyrcion factor.
37. •• Lahouassa H, Daddacha W, Hofmann H, Ayinde D, Logue EC, Dragin L, et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nat Immunol. 2012;13:223-8. Mechanism of action of SAMHD1 is defined in this important contribution and related to its ability to cleave and therefore deplete deoxynucleoside triphosphates and thus reduced the virus' ability to reverse transcribe in resting cells.
38. Wang YF, Holstein AF. Intraepithelial lymphocytes and macrophages in the human epididymis. Cell Tissue Res. 1983;233:517-21. (Pubitemid 14226906)
39. Wolff H. The biologic significance of white blood cells in semen. Fertil Steril. 1995;63:1143-57.
40. Smith DC, Barratt CL, Williams MA. The characterization of non-sperm cells in the ejaculates of fertile men using transmission electron microscopy. Andrologia. 1989;21:319-33. (Pubitemid 19209719)
41. Tremellen K, Tunc O. Macrophage activity in semen is significantly correlated with sperm quality in infertile men. Int J Androl. 2010;33:823-31.
42. Ochsendorf FR. Infections in the male genital tract and reactive oxygen species. Hum Reprod Updat. 1999;5:399-420. (Pubitemid 29512129)
43. Sharma RK, Pasqualotto AE, Nelson DR, Thomas Jr AJ, Agarwal A. Relationship between seminal white blood cell counts and oxidative stress in men treated at an infertility clinic. J Androl. 2001;22:575-83. (Pubitemid 32623077)
44. Henkel R, Maass G, Hajimohammad M, Menkveld R, Stalf T, Villegas J, et al. Urogenital inflammation: changes of leucocytes and ROS. Andrologia. 2003;35:309-13. (Pubitemid 37363523)
45. Ricci G, Perticarari S, Boscolo R, Simeone R, Martinelli M, Fischer-Tamaro L, et al. Leukocytospermia and sperm preparation - a flow cytometric study. Reprod Biol Endocrinol. 2009;7:128.
46. Riedel HH. Techniques for the detection of leukocytospermia in human semen. Arch Androl. 1980;5:287-93. (Pubitemid 11225658)
47. • Anderson DJ, Politch JA, Nadolski AM, Blaskewicz CD, Pudney J, Mayer KH. Targeting trojan horse leukocytes for HIV prevention. AIDS. 2010;24:163-87. Excellent overview of how infected cells in either the male and female genital tract have the potential to transmit virus to the next host.
48. Bagasra O, Farzadegan H, Seshamma T, Oakes JW, Saah A, Pomerantz RJ. Detection of HIV-1 proviral DNA in sperm from HIV-1-infected men. AIDS. 1994;8:1669-74. (Pubitemid 24357841)
49. Nuovo GJ, Becker J, Simsir A, Margiotta M, Khalife G, Shevchuk M. HIV-1 nucleic acids localize to the spermatogonia and their progeny. A study by polymerase chain reaction in situ hybridization. Am J Pathol. 1994;144:1142-8. (Pubitemid 24172075)
50. Muciaccia B, Uccini S, Filippini A, Ziparo E, Paraire F, Baroni CD, et al. Presence and cellular distribution of HIV in the testes of seropositive subjects: an evaluation by in situ PCR hybridization. FASEB J. 1998;12:151-63. (Pubitemid 28080185)
51. Bujan L, Daudin M, Matsuda T, Righi L, Thauvin L, Berges L, et al. Factors of intermittent HIV-1 excretion in semen and efficiency of sperm processing in obtaining spermatozoa without HIV-1 genomes. AIDS. 2004;18:757-66. (Pubitemid 38535003)
52. Persico T, Savasi V, Ferrazzi E, Oneta M, Semprini AE, Simoni G. Detection of human immunodeficiency virus-1 RNA and DNA by extractive and in situ PCR in unprocessed semen and seminal fractions isolated by semen-washing procedure. Hum Reprod. 2006;21:1525-30. (Pubitemid 44445031)
53. Quayle AJ, Xu C, Tucker L, Anderson DJ. The case against an association between HIV-1 and sperm: molecular evidence. J Reprod Immunol. 1998;41:127-36. (Pubitemid 29017870)
54. Politch JA, Mayer KH, Anderson DJ. Depletion of CD4+ T cells in semen during HIV infection and their restoration following antiretroviral therapy. J Acquir Immune Defic Syndr. 2009;50:283-9.
55. Muller CH, Coombs RW, Krieger JN. Effects of clinical stage and immunological status on semen analysis results in human immunodeficiency virus type 1-seropositive men. Andrologia. 1998;30 Suppl 1:15-22. (Pubitemid 28244188)
56. • Malim MH, Bieniasz PD. HIV restriction factors and mechanisms of evasion. Cold Spring Harb Perspect Med. 2012;2:a006940. Comprehensive overview of HIV restriction factors and the virus' ability to evade this reponse.
57. Kirchhoff F. Immune evasion and counteraction of restriction factors by HIV-1 and other primate lentiviruses. Cell Host Microbe. 2010;8:55-67.
58. Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, Block D, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A. 2004;101:6062-7. (Pubitemid 38520528)
59. Hirsch VM, Sharkey ME, Brown CR, Brichacek B, Goldstein S, Wakefield J, et al. Vpx is required for dissemination and pathogenesis of SIV(SM) PBj: evidence of macrophage-dependent viral amplification. Nat Med. 1998;4:1401-8. (Pubitemid 28553463)
60. Gibbs JS, Lackner AA, Lang SM, Simon MA, Sehgal PK, Daniel MD, et al. Progression to AIDS. in the absence of a gene for vpr or vpx. J Virol. 1995;69:2378-83.
61. Fujita M, Otsuka M, Miyoshi M, Khamsri B, Nomaguchi M, Adachi A. Vpx is critical for reverse transcription of the human immunodeficiency virus type 2 genome in macrophages. J Virol. 2008;82:7752-6. (Pubitemid 352031244)
62. Goujon C, Riviere L, Jarrosson-Wuilleme L, Bernaud J, Rigal D, Darlix JL, et al. SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells. Retrovirology. 2007;4:2. (Pubitemid 46189738)
63. Srivastava S, Swanson SK, Manel N, Florens L, Washburn MP, Skowronski J. Lentiviral Vpx accessory factor targets VprBP/DCAF1 substrate adaptor for cullin 4 E3 ubiquitin ligase to enable macrophage infection. PLoS Pathog. 2008;4:e1000059. (Pubitemid 351811530)
64. Lee J, Zhou P. DCAFs, the missing link of the CUL4-DDB1 ubiquitin ligase. Mol Cell. 2007;26:775-80. (Pubitemid 46921011)
65. Bergamaschi A, Ayinde D, David A, Le Rouzic E, Morel M, Collin G, et al. The human immunodeficiency virus type 2 Vpx protein usurps the CUL4A-DDB1 DCAF1 ubiquitin ligase to overcome a postentry block in macrophage infection. J Virol. 2009;83:4854-60.
66. Xie Y, Varshavsky A. Physical association of ubiquitin ligases and the 26S proteasome. Proc Natl Acad Sci U S A. 2000;97:2497-502. (Pubitemid 30159199)
67. Laguette N, Benkirane M. How SAMHD1 changes our view of viral restriction. TrendsImmunol. 2012;33:26-33.
68. Schultz J, Ponting CP, Hofmann K, Bork P. SAM as a protein interaction domain involved in developmental regulation. Protein Sci. 1997;6:249-53. (Pubitemid 27045264)
69. Aravind L, Koonin EV. The HD domain defines a new superfamily of metal-dependent phosphohydrolases. Trends Biochem Sci. 1998;23:469-72. (Pubitemid 29002909)
70. Goldstone DC, Ennis-Adeniran V, Hedden JJ, Groom HC, Rice GI, Christodoulou E, et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature. 2011;480:379-82.
71. Hofmann H, Logue EC, Bloch N, Daddacha W, Polsky SB, Schultz ML, et al. The Vpx lentiviral accessory protein targets SAMHD1 for degradation in the nucleus. J Virol. 2012;86:12552-60.
72. Brandariz-Nunez A, Valle-Casuso JC, White TE, Laguette N, Benkirane M, Brojatsch J, et al. Role of SAMHD1 nuclear localization in restriction of HIV-1 and SIVmac. Retrovirology. 2012;9:49.
73. Humbert JM, Frecha C, Amirache Bouafia F, N'Guyen TH, Boni S, Cosset FL, et al. Measles virus glycoprotein-pseudotyped lentiviral vectors are highly superior to vesicular stomatitis virus G pseudotypes for genetic modification of monocyte-derived dendritic cells. J Virol. 2012;86:5192-203.
74. • Pace MJ, Graf EH, Agosto LM, Mexas AM, Male F, Brady T, et al. Directly Infected resting CD4+T cells can produce HIV gag without spreading infection in a model of HIV latency. PLoS Pathog. 2012;8:e1002818. Important observation that resting CD4 T cells may be infected at low levels but cannot produce virus to allow spread. This observation impacts how we view HIV substrate availability and how the virus is spread.
75. Nowak MA, Bangham CR. Population dynamics of immune responses to persistent viruses. Science. 1996;272:74-9. (Pubitemid 26110757)
76. De Boer RJ, Perelson AS. Target cell limited and immune control models of HIV infection: a comparison. J Theor Biol. 1998;190:201-14. (Pubitemid 28132653)
77. May RM, Anderson RM. Population biology of infectious diseases: Part II. Nature. 1979;280:455-61. (Pubitemid 9234555)
78. Steinman RM. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol. 2012;30:1-22.
79. Miller MJ, Hejazi AS, Wei SH, Cahalan MD, Parker I. T cell repertoire scanning is promoted by dynamic dendritic cell behavior and random T cell motility in the lymph node. Proc Natl Acad Sci U S A. 2004;101:998-1003. (Pubitemid 38160573)
80. •• Aggarwal A, Iemma TL, Shih I, Newsome TP, McAllery S, Cunningham AL, et al. Mobilization of HIV spread by diaphanous 2 dependent filopodia in infected dendritic cells. PLoS Pathog. 2012;8:e1002762. Discovery that true filopodia from cells of myeloid lineage can launch HIV virions as they bud from the plasma membrane.
81. Clark EA. HIV: dendritic cells as embers for the infectious fire. Curr Biol. 1996;6:655-7. (Pubitemid 126656327)
82. Hu J, Miller CJ, O'Doherty U, Marx PA, Pope M. The dendritic cell-T cell milieu of the lymphoid tissue of the tonsil provides a locale in which SIV can reside and propagate at chronic stages of infection. AIDS Res Hum Retrovir. 1999;15:1305-14. (Pubitemid 29449409)
83. Pope M, Betjes MG, Romani N, Hirmand H, Cameron PU, Hoffman L, et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell. 1994;78:389-98. (Pubitemid 24250804)
84. Popov S, Chenine AL, Gruber A, Li PL, Ruprecht RM. Long-term productive human immunodeficiency virus infection of CD1a-sorted myeloid dendritic cells. J Virol. 2005;79:602-8. (Pubitemid 39648413)
85. Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med. 1999;5:512-7. (Pubitemid 29220209)
86. Gendelman HE, Orenstein JM, Martin MA, Ferrua C, Mitra R, Phipps T, et al. Efficient isolation and propagation of human immunodeficiency virus on recombinant colony-stimulating factor 1-treated monocytes. J Exp Med. 1988;167:1428-41.
87. Welsch S, Keppler OT, Habermann A, Allespach I, Krijnse-Locker J, Krausslich HG. HIV-1 buds predominantly at the plasma membrane of primary human macrophages. PLoS Pathog. 2007;3:e36. (Pubitemid 46535810)
88. Jouvenet N, Neil SJ, Bess C, Johnson MC, Virgen CA, Simon SM, et al. Plasma membrane is the site of productive HIV-1 particle assembly. PLoS Biol. 2006;4:e435. (Pubitemid 44917619)
89. Pelchen-Matthews A, Giese S, Mlcochova P, Turner J, Marsh M. beta2 integrin adhesion complexes maintain the integrity of HIV-1 assembly compartments in primary macrophages. Traffic. 2012;13:273-91.
90. Marsh M, Theusner K, Pelchen-Matthews A. HIV assembly and budding in macrophages. Biochem Soc Trans. 2009;37:185-9.
91. Chu H, Wang JJ, Qi M, Yoon JJ, Wen X, Chen X, et al. The intracellular virus-containing compartments in primary human macrophages are largely inaccessible to antibodies and small molecules. PLoS One. 2012;7:e35297.
92. Gousset K, Ablan SD, Coren LV, Ono A, Soheilian F, Nagashima K, et al. Real-time visualization of HIV-1 GAG trafficking in infected macrophages. PLoS Pathog. 2008;4:e1000015. (Pubitemid 351631101)
93. Bourinbaiar AS, Phillips DM. Transmission of human immunodeficiency virus from monocytes to epithelia. J Acquir Immune Defic Syndr. 1991;4:56-63.
94. Pearce-Pratt R, Malamud D, Phillips DM. Role of the cytoskeleton in cell-to-cell transmission of human immunodeficiency virus. J Virol. 1994;68:2898-905. (Pubitemid 24129737)
95. Turville SG, Aravantinou M, Stossel H, Romani N, Robbiani M. Resolution of de novo HIV production and trafficking in immature dendritic cells. Nat Methods. 2008;5:75-85.
96. Arhel N, Genovesio A, Kim KA, Miko S, Perret E, Olivo-Marin JC, et al. Quantitative four-dimensional tracking of cytoplasmic and nuclear HIV-1 complexes. Nat Methods. 2006;3:817-24. (Pubitemid 44445829)
97. Hubner W, Chen P, Del Portillo A, Liu Y, Gordon RE, Chen BK. Sequence of human immunodeficiency virus type 1 (HIV-1) Gag localization and oligomerization monitored with live confocal imaging of a replication-competent, fluorescently tagged HIV-1. J Virol. 2007;81:12596-607. (Pubitemid 350085873)
98. Muller B, Daecke J, Fackler OT, Dittmar MT, Zentgraf H, Krausslich HG. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. J Virol. 2004;78:10803-13. (Pubitemid 39258405)
99. Yang C, Czech L, Gerboth S, Kojima S, Scita G, Svitkina T. Novel roles of formin mDia2 in lamellipodia and filopodia formation in motile cells. PLoS Biol. 2007;5:e317. (Pubitemid 350276935)